BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse Capital Pear Therapeutics Atlas Venture Mirum Pharmaceuticals Genoimmune Therapeutics OBiO Technology (Shanghai) Co. Ltd. Beijing...
Items per page:
1 - 1 of 1
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse Capital Pear Therapeutics Atlas Venture Mirum Pharmaceuticals Genoimmune Therapeutics OBiO Technology (Shanghai) Co. Ltd. Beijing...
Items per page:
1 - 1 of 1